Integrated financial results for the quarter and year ended 31st March 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CDG Petchem reported widened losses for FY25, with standalone net loss deepening to ₹105.75 lakhs (vs ₹91.64 lakhs in FY24) and consolidated net loss more than doubling to ₹115.14 lakhs (vs ₹55.28 lakhs). Revenue from operations fell sharply — standalone revenue dropped ~42% to ₹898.73 lakhs and consolidated revenue fell ~43% to ₹2,309.97 lakhs, reflecting a steep business slowdown. The consolidated cash flow statement shows a sharp swing into negative operating cash flow of ₹(721.51) lakhs (vs ₹114.19 lakhs positive last year), driven largely by working capital changes and repayment of current borrowings. On the balance sheet, standalone equity has eroded into negative territory at ₹(20.63) lakhs (vs ₹85.12 lakhs), although long-term borrowings have been paid down to ₹24.26 lakhs. No loan or debt security defaults were reported, and the statutory auditor issued an unqualified opinion on both standalone and consolidated results.
Shareholders face continued value erosion — declining revenues, widening losses, negative operating cash flow, and standalone negative equity point to serious financial stress. The stock price is likely to remain under pressure unless revenue recovers and the company returns to profitability.